99 related articles for article (PubMed ID: 6858796)
1. [Value of bladder lavage in the follow-up of urothelial pathology].
Wallon J; Van Cangh PJ
Acta Urol Belg; 1983; 51(1):32-7. PubMed ID: 6858796
[No Abstract] [Full Text] [Related]
2. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
[TBL] [Abstract][Full Text] [Related]
4. Urine cytology in the follow-up of patients with transitional cell carcinoma of the urinary bladder: is that enough as a single method?
Raica M; Miclea F; Ioiart I; Minciu R; Drăgan P
Rom J Morphol Embryol; 1998; 44(1-4):173-8. PubMed ID: 15678859
[TBL] [Abstract][Full Text] [Related]
5. [What is the value of urine cytology in after-care of patients with urothelial cancers?].
Möllhoff S; Rathert P
Urologe A; 1992 Jul; 31(4):203-5. PubMed ID: 1514198
[No Abstract] [Full Text] [Related]
6. [Urine cytology in the diagnosis of urothelium tumors].
Rona-Selnic G
Med Lab (Stuttg); 1982; 35(6):158-62. PubMed ID: 7162453
[No Abstract] [Full Text] [Related]
7. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
[TBL] [Abstract][Full Text] [Related]
8. Nuclear matrix protein 22 as adjunct to urine cytology and cystoscopy in follow-up of superficial TCC of urinary bladder.
Gupta NP; Sharma N; Kumar R
Urology; 2009 Mar; 73(3):592-6; discussion 596-7. PubMed ID: 19168205
[TBL] [Abstract][Full Text] [Related]
9. Intermediate-risk urothelial carcinoma: an unresolved problem?
Pycha A; Lodde M; Comploj E; Negri G; Egarter-Vigl E; Vittadello F; Lusuardi L; Palermo S; Mian C
Urology; 2004 Mar; 63(3):472-5. PubMed ID: 15028440
[TBL] [Abstract][Full Text] [Related]
10. [Urinary cytology of transitional-cell carcinoma].
Piazza G; Galia A; Cosentino A; Grasso G
Pathologica; 1995 Apr; 87(2):146-7. PubMed ID: 8532407
[TBL] [Abstract][Full Text] [Related]
11. [Combined cytology/cytometry for preventing misinterpretations of urine cytology].
vom Dorp F
Urologe A; 2007 Sep; 46(9):1140-1. PubMed ID: 17665165
[No Abstract] [Full Text] [Related]
12. Cytohistological study of urinary bladder neoplasms.
Misra V; Gupta SC; Tandon SP; Gupta AK; Sircar S
Indian J Pathol Microbiol; 2000 Jul; 43(3):303-9. PubMed ID: 11218677
[TBL] [Abstract][Full Text] [Related]
13. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder.
Rosen EM; Joseph A; Jin L; Yao Y; Chau MH; Fuchs A; Gomella L; Hastings H; Goldberg ID; Weiss GH
J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6/10 ratio as a prognostic marker of recurrence in patients with intermediate risk urothelial bladder carcinoma.
Cai T; Mazzoli S; Meacci F; Tinacci G; Nesi G; Zini E; Bartoletti R
J Urol; 2007 Nov; 178(5):1906-11;discussion 1911-2. PubMed ID: 17868727
[TBL] [Abstract][Full Text] [Related]
15. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
[TBL] [Abstract][Full Text] [Related]
16. [The role of urinary cytology in the diagnosis of neoplasms of the upper excretory tract. Cyto-histological correlations in 29 cases].
Mincione GP; Muraro GB; Pecori M; Rossi I
Pathologica; 1983; 75(1036):181-6. PubMed ID: 6634230
[No Abstract] [Full Text] [Related]
17. Editorial comment on: Microsatellite analysis of voided-urine samples for surveillance of low-grade non-muscle-invasive urothelial carcinoma: feasibility and clinical utility in a prospective multicenter study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer trial CEFUB).
van der Poel HG
Eur Urol; 2009 Mar; 55(3):667-8. PubMed ID: 18501500
[No Abstract] [Full Text] [Related]
18. Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer.
Tzai TS; Tsai YS; Shiau AL; Wu CL; Shieh GS; Tsai HT
Urology; 2006 Feb; 67(2):294-9. PubMed ID: 16461079
[TBL] [Abstract][Full Text] [Related]
19. Urinary cytokeratin 20 mRNA expression has the potential to predict recurrence in superficial transitional cell carcinoma of the bladder.
Christoph F; Weikert S; Wolff I; Schostak M; Tabiti K; Müller M; Miller K; Schrader M
Cancer Lett; 2007 Jan; 245(1-2):121-6. PubMed ID: 16473461
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer.
Wiener HG; Vooijs GP; van't Hof-Grootenboer B
Acta Cytol; 1993; 37(2):163-9. PubMed ID: 8465635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
